Masimo (MASI)
(Delayed Data from NSDQ)
$143.49 USD
+3.55 (2.54%)
Updated Oct 9, 2024 04:00 PM ET
After-Market: $143.53 +0.04 (0.03%) 6:30 PM ET
2-Buy of 5 2
C Value A Growth C Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$143.49 USD
+3.55 (2.54%)
Updated Oct 9, 2024 04:00 PM ET
After-Market: $143.53 +0.04 (0.03%) 6:30 PM ET
2-Buy of 5 2
C Value A Growth C Momentum B VGM
Zacks News
Integra Lifesciences Picked for Healogics iSupply Program
by Zacks Equity Research
Integra Lifesciences' (IART) selection as a key provider for cellular-based tissue products within Healogics' new iSupply program to boost the top line.
Varian Up on Tie-Up With Kenya's Mediheal Group of Hospitals
by Zacks Equity Research
Varian's (VAR) advanced cancer care solution prospects bright in the global market.
Here's Why You Should Invest in Surmodics (SRDX) Stock Now
by Zacks Equity Research
Continuous focus on R&D and a raised guidance for fiscal 2018 make Surmodics (SRDX) a lucrative pick for investors.
IDEXX Gains Ground on Solid CAG Business Amid Forex Woes
by Zacks Equity Research
IDEXX (IDXX) continues to see strong organic growth, driven by solid sales at the CAG business. However, unfavorable currency movement remains a concern.
Here's Why You Should Hold On to Quest Diagnostics (DGX) Now
by Zacks Equity Research
Tough competitive landscape and reimbursement issues are major deterrents to Quest Diagnostics' (DGX) top line in the near term. The company's focus on promising areas to drive growth is a positive.
Boston Scientific to Boost MedSurg Unit Via Augmenix Buyout
by Zacks Equity Research
Boston Scientific (BSX) continues to adopt organic as well as inorganic means to boost top line.
Penumbra Launches Reperfusion Catheters, Boosts Neuro Unit
by Zacks Equity Research
Penumbra (PEN) adopts initiatives to boost the highest revenue generating Neuro business.
Genomic Health Prostate Cancer Business Solid, Cost Woes Stay
by Zacks Equity Research
Within the prostate cancer space, Genomic Health (GHDX) is seeing increasing private coverage for the Oncotype DX GPS test. Costs and operating expenses continue to rise.
Here's Why You Should Invest in athenahealth (ATHN) Now
by Zacks Equity Research
Focus on cloud-based services and a lifted guidance for 2018 make athenahealth (ATHN) an attractive pick.
Varian's (VAR) ProBeam System Gets Picked by Delray Medical
by Zacks Equity Research
Varian Medical's (VAR) coveted ProBeam platform sees a slew of developments; market prospects solid.
Here's Why You Should Hold on to Abiomed (ABMD) for Now
by Zacks Equity Research
Abiomed's (ABMD) margin continues to remain pressed; an upbeat view for fiscal 2019 encourages.
Amedisys Ties Up With Medalogix to Boost Home Health Unit
by Zacks Equity Research
Amedisys (AMED) pursues deals to boost Home Health business.
Here's Why You Should Invest in Veeva (VEEV) Stock Right Now
by Zacks Equity Research
Strong fundamentals and a solid Q2 aid Veeva (VEEV).
Illumina MiSeq Dx Okayed in China, NGS Platform Gets a Boost
by Zacks Equity Research
Illumina's (ILMN) receipt of CNDA approval for MiSeq Dx Sequencing System is expected to expand customer base and boost the top line.
Here's Why You Should Invest in Phibro (PAHC) Right Now
by Zacks Equity Research
Phibro (PAHC) sees improvement across all segments. The Animal Health business has been a key contributor.
Here's Why You Should Buy Inogen (INGN) Stock Right Now
by Zacks Equity Research
Inogen (INGN) gains from strong Q2 results and bright global prospects.
Here's Why You Should Invest in Genomic Health (GHDX) Now
by Zacks Equity Research
Genomic Health (GHDX) gains ground on growing adoption of prostate cancer test and solid international scenario.
Ecolab's Nalco Pairs With XOS to Boost Global Energy Unit
by Zacks Equity Research
Ecolab's (ECL) Nalco Champion's 3D CRUDEFLEX will integrate XOS' Clora Online; market prospects bright.
New Buyouts Aid Boston Scientific Amid Dull Pacemaker Sales
by Zacks Equity Research
Boston Scientific (BSX) continues to adopt organic as well as inorganic routes for success. However, sluggish global pacemaker sales continue to disappoint.
Wright Medical Buys Cartiva to Boost Lower Extremities Unit
by Zacks Equity Research
Wright Medical's (WMGI) addition of Synthetic Cartilage Implant is likely to drive revenues in 2019; raised guidance for 2018 encourages.
STERIS (STE) Strategic Growth Strong, Competition a Woe
by Zacks Equity Research
STERIS' (STE) beneficial underlying market trends along with new product and service offerings are impressive. Meanwhile, the company worries over facing a severe competition.
Bruker to Expand Molecular Diagnostics Arm With Hain Buyout
by Zacks Equity Research
Hain's molecular diagnostics solutions of bacterial and viral infections are expected to compliment Bruker's (BRKR) MALDI Biotyper and IR Biotyper microbiology platforms.
Omnicell Patient Engagement Unit to Aid Medication Adherence
by Zacks Equity Research
Omnicell's (OMCL) revamped Patient Engagement platform likely to aid core Medication Adherence Unit; market looks promising.
Tap the Sleep Apnea Devices Market Boom With These 3 Stocks
by Sweta Jaiswal
Consider these three stocks in the sleep apnea devices market for grand returns.
Hill-Rom (HRC) Touches 52-Week High: What's Driving It?
by Zacks Equity Research
Hill-Rom (HRC) rides high on impressive Q3 results along with increased focus on product innovation through research and development.